Subscribe
vasanty / Shutterstock.com
30 September 2025NewsEuropeMarisa Woutersen

EPO ruling clarifies appeal rights, blocking third-party intervention

A landmark decision sees the European Patent Office confirm that once all original appeals are withdrawn, third-party interveners cannot continue proceedings. 

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Jury sides with Allergan in $56M Botox tech feud
22 July 2025   $56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues.
Europe
La Prairie accused of stealing caviar biotech for luxury skincare line
4 March 2025   UK biotech firm accuses luxury skincare brand La Prairie of misappropriating proprietary research on caviar-derived ingredients | Lawsuit claims La Prairie lacked expertise to develop the tech before accessing confidential trade secrets.
Big Pharma
Swiss watchdog investigates Novartis over patent use
20 September 2022   Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition


Editor's picks

Data and delivery: Inside AI's inventorship dilemma
Americas
Data and delivery: Inside AI's inventorship dilemma
21 October 2025

Editor's picks

Americas
Data and delivery: Inside AI's inventorship dilemma
21 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
13 October 2025
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
1 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025

More features

Data and delivery: Inside AI's inventorship dilemma
Weil continues expansion with top trade secrets litigator
Top pharma, biotech, and medtech experts gather at LSPN Fall
Mitsubishi Tanabe doubles down on Radicava protection
‘All it takes is a post on Truth Social’: Is this patent reform's moment?
Novartis fails to block repackaged imports of blockbuster treatment
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
Protect early, partner wisely: In-house tips for medtech startups